Evidence map›Paper›PMID 40221591›Full record

ArticleCommunications chemistry2025

The RMaP challenge of predicting RNA modifications by nanopore sequencing.

Jannes Spangenberg, Stefan Mündnich, Anne Busch, Stefan Pastore, Anna Wierczeiko, Winfried Goettsch, Vincent Dietrich, Leszek P Pryszcz, Sonia Cruciani, Eva Maria Novoa and 14 more

Abstract read
In one paragraph

Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Jannes SpangenbergRNA Bioinformatics, Friedrich-Schiller-University Jena, Leutragraben 1, 07743, Jena, Germany.ORCID http://orcid.org/0000-0002-6126-411X
Stefan MündnichInstitute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, 55128, Mainz, Germany.ORCID http://orcid.org/0009-0005-0737-6638
Anne BuschInstitute for Informatics, Johannes Gutenberg-University Mainz, 55128, Mainz, Germany.ORCID http://orcid.org/0009-0002-7955-821X
Stefan PastoreInstitute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, 55128, Mainz, Germany.
Anna WierczeikoInstitute for Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Winfried GoettschRNA Bioinformatics, Friedrich-Schiller-University Jena, Leutragraben 1, 07743, Jena, Germany.ORCID http://orcid.org/0000-0003-1015-0726
Vincent DietrichInstitute for Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Leszek P PryszczCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona, 08003, Spain.ORCID http://orcid.org/0000-0003-0790-067X
Sonia CrucianiCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona, 08003, Spain.
Eva Maria NovoaCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona, 08003, Spain.
Kandarp JoshiDepartment of Neurosurgery, Oncology, Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, 1650 Orleans St, Baltimore, MD, 21231, USA.ORCID http://orcid.org/0000-0002-2153-0110
Ranjan PereraDepartment of Neurosurgery, Oncology, Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, 1650 Orleans St, Baltimore, MD, 21231, USA.
Salvatore Di GiorgioDivision of Immune Diversity, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-1419-717X
Paola ArrubarrenaDepartment of Mathematics at Imperial College London, London, SW7 2AZ, UK.
Irem TelliogluDivision of Immune Diversity, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-0049-789X
Chi-Lam PoonComputational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Yuk Kei WanGenome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Republic of Singapore.
Jonathan GökeGenome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Republic of Singapore.
Andreas HildebrandtInstitute for Informatics, Johannes Gutenberg-University Mainz, 55128, Mainz, Germany.ORCID http://orcid.org/0000-0003-2180-6516
Christoph DieterichKlaus Tschira Institute for Integrative Computational Cardiology, University Hospital Heidelberg, Im Neuenheimer Feld 669, 69120, Heidelberg, Germany. christoph.dieterich@uni-heidelberg.de.
Mark HelmInstitute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, 55128, Mainz, Germany. mhelm@uni-mainz.de.
Manja MarzRNA Bioinformatics, Friedrich-Schiller-University Jena, Leutragraben 1, 07743, Jena, Germany. manja@uni-jena.de.
Susanne GerberInstitute for Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. sugerber@uni-mainz.de.ORCID http://orcid.org/0000-0001-9513-0729
Nicolo AlagnaInstitute for Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. nalagna@uni-mainz.de.ORCID http://orcid.org/0009-0006-0804-5774

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Regulation, function, and the therapeutic potential of an oncogenic long noncoding RNA lnc-HLX-2-7 in group 3 medulloblastomasR01NS124668 · NINDS · JOHNS HOPKINS UNIVERSITY · PI Ranjan Joseph Perera · 2022 to 2026
$2.1M
NCI NIH HHS P30 CA008748NINDS NIH HHS R01 NS124668
6 · The paper itself

Abstract

The field of epitranscriptomics is undergoing a technology-driven revolution. During past decades, RNA modifications like N6-methyladenosine (m

Identifiers

PMID40221591
PMCPMC11993749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.